medigraphic.com
ISSN 2007-1523 (Digital)
Revista Mexicana de Trastornos Alimentarios

2024, Número 2

<< Anterior

Revista Mexicana de Trastornos Alimentarios 2024; 14 (2)


La activación sistémica de los receptores a dopamina D2-like disminuye la ingesta de alimento en ratas

Tejas-Juárez JG, Cruz-Trujillo R, Díaz-Gandarilla JA, Escartín-Pérez RE, Florán-Garduño B

Idioma: Español
Referencias bibliográficas: 31
Paginas: 209-221
Archivo PDF: 421.32 Kb.


RESUMEN

México ocupa el quinto lugar en incidencia de obesidad a nivel mundial. Esta condición es un factor de riesgo para la ocurrencia de cardiopatías, Diabetes Mellitus tipo II, cáncer, complicaciones reproductivas y trastornos psicológicos, entre otras patologías. Dado que la dopamina regula el comportamiento alimentario, es crucial investigar cómo los receptores dopaminérgicos pueden mejorar las intervenciones farmacológicas contra la obesidad. En consecuencia, en el presente trabajo se estudió el efecto de la activación farmacológica sistémica de los receptores dopaminérgicos de la familia D2-like (D2, D3 y D4) sobre la ingesta de alimento estándar y la expresión de la saciedad. Se usaron ratas macho (cepa Wistar) con un peso de 220-240 g, a las que se les administraron subcutáneamente dosis de 0.03, 0.1 o 0.3 mg/kg de quinpirole (agonista D2-like) al inicio de la fase oscura del ciclo luz/ oscuridad. Durante un periodo de dos horas, se evaluó tanto la ingesta de alimento estándar como la secuencia de saciedad conductual (SSC). Nuestros resultados indican que las dosis de 0.03 y 0.1 mg/ kg disminuyen la ingesta de alimento sin alterar la expresión de la saciedad postprandial. Sin embargo, la dosis de 0.3 mg/kg desestabiliza la SSC, impidiendo la expresión de la saciedad debido a un efecto motor. Nuestros hallazgos sugieren que dosis bajas de quinpirole podrían ofrecer una opción para el tratamiento de la obesidad sin afectar la expresión de la saciedad postprandial.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alcalde-Rabanal, J. E., Orozco-Núñez, E., Espinosa-Henao,O. E., Arredondo-López, A., & Alcayde-Barranco,L. (2018). The complex scenario of obesity, diabetesand hypertension in the area of influence of primaryhealthcare facilities in Mexico. PloS One, 13(1), e0187028.https://doi.org/10.1371/journal.pone.0187028

  2. Baladi, M. G., Newman, A. H., & France, C. P. (2010). DopamineD3 receptors mediate the discriminative stimuluseffects of quinpirole in free-feeding rats. The Journal ofPharmacology and Experimental Therapeutics, 332(1), 308–315. https://doi.org/10.1124/jpet.109.158394

  3. Barrea, L., Pugliese, G., Muscogiuri, G., Laudisio, D., Colao,A., & Savastano, S. (2020). New-generation anti-obesitydrugs: naltrexone/bupropion and liraglutide. Anupdate for endocrinologists and nutritionists. MinervaEndocrinologica, 45(2), 127–137. https://doi.org/10.23736/S0391-1977.20.03179-X

  4. Cooper, S. J., & Al-Naser, H. A. (2006). Dopaminergic controlof food choice: contrasting effects of SKF 38393and quinpirole on high-palatability food preference inthe rat. Neuropharmacology, 50(8), 953–963. https://doi.org/10.1016/j.neuropharm.2006.01.006

  5. Costall, B., Hendrie, C. A., Kelly, M. E., & Naylor, R. J. (1987).Actions of sulpiride and tiapride in a simple model ofanxiety in mice. Neuropharmacology, 26(2-3), 195–200.https://doi.org/10.1016/0028-3908(87)90209-7

  6. Eilam, D., & Szechtman, H. (1989). Biphasic effect of D-2agonist quinpirole on locomotion and movements. EuropeanJournal of Pharmacology, 161(2-3), 151–157. https://doi.org/10.1016/0014-2999(89)90837-6

  7. Gadde, K. M., Martin, C. K., Berthoud, H. R. & Heymsfield,S. B. (2018). Obesity: Pathophysiology and Management.Journal of the American College of Cardiology, 71(1),69–84. https://doi.org/10.1016/j.jacc.2017.11.011

  8. Halford, J. C., Wanninayake, S. C. & Blundell, J. E. (1998).Behavioral satiety sequence (BSS) for the diagnosis ofdrug action on food intake. Pharmacology, Biochemistry,and Behavior, 61(2), 159–168. https://doi.org/10.1016/s0091-3057(98)00032-x

  9. Huang, J. J., Yen, C. T., Liu, T. L., Tsao, H. W., Hsu, J. W. &Tsai, M. L. (2013). Effects of dopamine D2 agonist quinpiroleon neuronal activity of anterior cingulate cortexand striatum in rats. Psychopharmacology, 227(3), 459–466. https://doi.org/10.1007/s00213-013-2965-4

  10. Kuo, D. Y. (2002). Co-administration of dopamine D1 andD2 agonists additively decreases daily food intake,body weight and hypothalamic neuropeptide Y level inrats. Journal of Biomedical Science, 9(2), 126–132. https://doi.org/10.1007/BF02256023

  11. Kuo, D. Y. (2003). Further evidence for the mediation ofboth subtypes of dopamine D1/D2 receptors and cerebralneuropeptide Y (NPY) in amphetamine-inducedappetite suppression. Behavioural Brain Research, 147(1-2), 149–155. https://doi.org/10.1016/j.bbr.2003.04.001

  12. Ladenheim, E. E. (2015). Liraglutide and obesity: a review ofthe data so far. Drug Design, Development and Therapy, 9,1867–1875. https://doi.org/10.2147/DDDT.S58459

  13. López-Alonso, V. E., Hernández-Correa, S., Escobar, C., Escartín-Pérez, R. E., Mancilla-Díaz, J. M. & Díaz-Urbina,D. (2023). The central blockade of the dopamine DR4receptor decreases sucrose consumption by modifyingthe microstructure of drinking behavior in malerats. IBRO Neuroscience Reports, 14, 195–201. https://doi.org/10.1016/j.ibneur.2023.02.001

  14. Malmberg, A. & Mohell, N. (1995). Characterization of [3H]quinpirole binding to human dopamine D2A and D3receptors: effects of ions and guanine nucleotides. TheJournal of Pharmacology and Experimental Therapeutics,274(2), 790–797.

  15. Mirmohammadsadeghi, Z., Shareghi Brojeni, M., Haghparast,A. & Eliassi, A. (2018). Role of paraventricularhypothalamic dopaminergic D1 receptors in food intakeregulation of food-deprived rats. European Journalof Pharmacology, 818, 43–49. https://doi.org/10.1016/j.ejphar.2017.10.028

  16. Missale, C., Nash, S. R., Robinson, S. W., Jaber, M. & Caron,M. G. (1998). Dopamine receptors: from structure tofunction. Physiological reviews, 78(1), 189–225. https://doi.org/10.1152/physrev.1998.78.1.189

  17. Palmiter, R. D. (2007). Is dopamine a physiologicallyrelevant mediator of feeding behavior?. Trends inNeurosciences, 30(8), 375–381. https://doi.org/10.1016/j.tins.2007.06.004

  18. Rowlett, J. K., Mattingly, B. A. & Bardo, M. T. (1995). Repeatedquinpirole treatment: locomotor activity,dopamine synthesis, and effects of selective dopamineantagonists. Synapse, 20(3), 209–16. doi: 10.1002/syn.890200304. PMID: 7570352.

  19. Rusk, I. N. & Cooper, S. J. (1988). Profile of the selectivedopamine D-2 receptor agonist N-0437: its effects onpalatability- and deprivation-induced feeding, and operantresponding for food. Physiology & Behavior, 44(4-5),545–553. https://doi.org/10.1016/0031-9384(88)90317-4

  20. Saebi Rad, F., Haghparast, A. & Eliassi, A. (2020). VentralTegmental Area Microinjected-SKF38393 IncreasesRegular Chow Intake in 18 Hours Food-Deprived Rats.Basic and Clinical Neuroscience, 11(6), 773–780. https://doi.org/10.32598/bcn.11.6.2226.1

  21. Shamah-Levy, T., Romero-Martínez, M., Barrientos-Gutiérrez,T., Cuevas-Nasu, L., Bautista-Arredondo, S.,Colchero, M.A., Gaona-Pineda, E.B., Lazcano-Ponce,E., Martínez-Barnetche, J., Alpuche-Arana, C., Rivera-Dommarco, J. (2022). Encuesta Nacional de Salud yNutrición 2021 sobre Covid-19. Resultados nacionales. InstitutoNacional de Salud Pública.

  22. Starr, B. S., & Starr, M. S. (1986). Grooming in the mouseis stimulated by the dopamine D1 agonist SKF 38393and by low doses of the D1 antagonist SCH 23390,but is inhibited by dopamine D2 agonists, D2 antagonistsand high doses of SCH 23390. Pharmacology,Biochemistry, and Behavior, 24(4), 837–839. https://doi.org/10.1016/0091-3057(86)90421-1

  23. Stuchlik, A., Rehakova, L., Rambousek, L., Svoboda, J. &Vales, K. (2007). Manipulation of D2 receptors withquinpirole and sulpiride affects locomotor activitybefore spatial behavior of rats in an active placeavoidance task. Neuroscience Research, 58(2), 133-9. doi:10.1016/j.neures.2007.02.006. Epub 2007 Feb 16. PMID:17360063.

  24. Tejas Juárez, J. G., Mancilla Díaz, J. M., Florán Garduño,B. & Escartín Pérez, R. E. (2010). Los receptores dopaminérgicosD2/D3 hipotalámicos participan enla regulación del comportamiento alimentario. RevistaMexicana de Análisis de la Conducta, 36(2), 53-69.Recuperado en 17 de agosto de 2023, de http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0185-45342010000200005&lng=es&tlng=es.

  25. Tejas-Juárez, J. G., Cruz-Martínez, A. M., López-Alonso,V. E., García-Iglesias, B., Mancilla-Díaz, J. M.,Florán-Garduño, B. & Escartín-Pérez, R. E. (2014).Stimulation of dopamine D4 receptors in the paraventricularnucleus of the hypothalamus of male ratsinduces hyperphagia: involvement of glutamate. Physiology& Behavior, 133, 272–281. https://doi.org/10.1016/j.physbeh.2014.04.040

  26. Terry, P., Gilbert, D. B. & Cooper, S. J. (1995). Dopaminereceptor subtype agonists and feeding behavior.Obesity Research, 3 Suppl 4, 515S–523S. https://doi.org/10.1002/j.1550-8528.1995.tb00221.x

  27. Ukai, M., Nakayama, S., & Kameyama, T. (1988). Apomorphinemarkedly potentiates naltrexone-inducedhypodipsia in the rat. Brain Research, 451(1-2), 357–360.https://doi.org/10.1016/0006-8993(88)90784-6

  28. Valdés Miramontes, E.H., Enciso Ramírez, M.A., FonsecaBustos, V. & Pineda Lozano, J.E. (2022). Obesity, energyintake and eating behavior: A review of the mainfactors involved / Obesidad, ingesta energética ycomportamiento alimentario: Una revisión de losprincipales factores involucrados. Revista Mexicanade Trastornos Alimentarios/Mexican Journal ofEating Disorders. 10(3), 308-320. https://doi.org/10.22201/fesi.20071523e.2019.2.563

  29. Wellman P. J. (2008). Systemic mazindol reduces foodintake in rats via suppression of meal size and mealnumber. Journal of Psychopharmacology (Oxford, England),22(5), 532–535. https://doi.org/10.1177/0269881107083837

  30. Yonemochi, N., Ardianto, C., Yang, L., Yamamoto, S.,Ueda, D., Kamei, J., Waddington, J. L. & Ikeda, H.(2019). Dopaminergic mechanisms in the lateral hypothalamusregulate feeding behavior in associationwith neuropeptides. Biochemical and Biophysical ResearchCommunications, 519(3), 547–552. https://doi.org/10.1016/j.bbrc.2019.09.037

  31. Zarrindast, M. R., Owji, A. A. & Hosseini-Nia, T. (1991).Evaluation of dopamine receptor involvement in ratfeeding behaviour. General Pharmacology, 22(6), 1011–1016. https://doi.org/10.1016/0306-3623(91)90570-v




2020     |     www.medigraphic.com